Hui Che
Wuhu, 241002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Correction: p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle.
Journal: eLife
Published: August 24, 2026
Ameliorative effect of Polygonatum cyrtonema Hua polysaccharide on HFD/STZ-induced type 2 diabetes mice via improving gut microbiota imbalance and glucose metabolism disorder.
Journal: International journal of biological macromolecules
Published: February 08, 2026
Mechanistic study on combined application of Puerariae Lobatae Radix polysaccharide and betaine in ameliorating hepatic and intestinal injury via regulating TLR4 signaling pathway in alcoholic liver disease mice
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: January 09, 2026
Hyperoside alleviates myocardial ischemia-reperfusion injury in rats by activating PKC/mito KATP signaling pathway
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: January 08, 2026
Ramulus Mori alkaloids (SZ-A) sensitize triple-negative breast cancer to cisplatin via PLA2G2A-mediated ceramide metabolism.
Journal: Chinese journal of natural medicines
Published: November 10, 2025
A novel fructan from Atractylodes macrocephala ameliorates ulcerative colitis through gut microbiota-mediated PI3K/Akt signaling.
Journal: Carbohydrate polymers
Published: September 30, 2025
Proteomic ratio reveals subtype-specific genetic mechanisms and therapeutic targets in osteoarthritis.
Journal: Clinical proteomics
Published: August 23, 2025
Preliminary Exploration of Discriminative Correlation Filter Network for Real-time Tracking of Inconspicuous Focal Liver Lesions on Conventional Ultrasound.
Journal: Ultrasound in medicine & biology
Published: August 07, 2025
Structural polysaccharide PCP1 from Polygonatum cyrtonema Hua attenuates atherosclerosis via dual-target suppression of CD36/MSR1 and TLR4/NF-κB pathways.
Journal: International immunopharmacology
Published: July 24, 2025
Last Updated: 09/26/2026